DM Medical Oncology (Immunotherapy & Targeted Therapy and Palliative & Supportive Care) — Thesis Title List
48 titles · instant objectives
-
001
Immune-related adverse events with checkpoint inhibitors across solid tumours: incidence, management and outcome
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
002
PD-L1 expression and its correlation with response to immunotherapy in non-small cell lung cancer and urothelial carcinoma
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
003
Efficacy and toxicity of tyrosine kinase inhibitors in metastatic renal cell carcinoma: a real-world analysis
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
004
Biosimilar versus innovator trastuzumab in HER2-positive breast cancer: response and safety
Immunotherapy & Targeted Therapy
Prospective comparative study
Comparative Study
-
005
Clinical utility of next-generation sequencing in advanced solid tumours: actionable mutations and treatment impact
Immunotherapy & Targeted Therapy
Prospective observational study
Descriptive Study
-
006
Symptom burden, quality of life and palliative care needs in patients with advanced cancer using ESAS and EORTC QLQ-C30
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
007
Prevalence and management of cancer pain and adequacy of analgesia using the WHO ladder in a tertiary oncology centre
Palliative & Supportive Care
Prospective observational study
Cross-sectional Study
-
008
Chemotherapy-induced nausea and vomiting: adherence to antiemetic guidelines and control rates
Palliative & Supportive Care
Prospective audit
Audit
-
009
Prevalence of malnutrition in cancer patients using PG-SGA and its impact on chemotherapy tolerance
Palliative & Supportive Care
Prospective observational study
Cross-sectional Study
-
010
Depression, anxiety and financial toxicity in patients undergoing chemotherapy and their effect on treatment adherence
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
011
Chemotherapy-induced peripheral neuropathy with taxanes and platinum agents: incidence, risk factors and impact on quality of life
Palliative & Supportive Care
Prospective observational study
Prospective Study
-
012
Adherence to oral anticancer agents and factors affecting it in patients with chronic myeloid leukaemia and breast cancer
Palliative & Supportive Care
Prospective observational study
Cross-sectional Study
-
013
Response assessment with PET-CT versus contrast CT in lymphoma and solid tumours: concordance and impact on management
Immunotherapy & Targeted Therapy
Prospective observational study
Diagnostic Study
-
014
Financial toxicity and out-of-pocket expenditure in cancer care at a public tertiary hospital
Palliative & Supportive Care
Cross-sectional study
Cross-sectional Study
-
015
Anaemia in cancer patients on chemotherapy: prevalence, etiology and response to intravenous iron and erythropoietin
Palliative & Supportive Care
Prospective observational study
Prospective Study
-
016
Low-dose versus standard-dose immune checkpoint inhibitors in advanced solid tumours: response, toxicity and cost
Immunotherapy & Targeted Therapy
Prospective comparative study
Comparative Study
-
017
Baseline neutrophil-lymphocyte ratio as a predictor of response to immune checkpoint inhibitors
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
018
Incidence and predictors of hyperprogressive disease on immune checkpoint inhibitors
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
019
Tumour mutational burden on next-generation sequencing and outcome with immunotherapy in advanced solid tumours
Immunotherapy & Targeted Therapy
Prospective observational study
Descriptive Study
-
020
Safety and outcome of immune checkpoint inhibitor rechallenge after immune-related adverse events
Immunotherapy & Targeted Therapy
Retrospective record-based study
Descriptive Study
-
021
Real-world toxicity profile of antibody-drug conjugates in metastatic breast and gastric cancer
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
022
Tuberculosis reactivation in patients receiving immune checkpoint inhibitors in a high tuberculosis burden setting
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
023
Prevalence of drug interactions between oral tyrosine kinase inhibitors and acid-suppressive therapy
Immunotherapy & Targeted Therapy
Hospital-based cross-sectional study
Cross-sectional Study
-
024
Uptake of immunotherapy through patient assistance programmes and factors affecting access
Immunotherapy & Targeted Therapy
Hospital-based cross-sectional study
Cross-sectional Study
-
025
Early integrated palliative care versus standard oncology care on quality of life in advanced cancer
Palliative & Supportive Care
Prospective comparative study
Comparative Study
-
026
Olanzapine 5 mg versus 10 mg for prevention of chemotherapy-induced nausea and vomiting
Palliative & Supportive Care
Prospective comparative study
Comparative Study
-
027
Prevalence and correlates of cancer-related fatigue in patients receiving chemotherapy
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
028
Biosimilar pegfilgrastim as primary prophylaxis: incidence of febrile neutropenia and dose delays
Palliative & Supportive Care
Prospective observational study
Prospective Study
-
029
Prevalence and management of opioid-induced constipation in patients with cancer pain
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
030
Incidence and severity of hand-foot syndrome with capecitabine and its effect on dose intensity
Palliative & Supportive Care
Prospective observational study
Prospective Study
-
031
Caregiver burden and its determinants among caregivers of patients with advanced cancer
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
032
Awareness and preferences for advance care planning among patients with advanced cancer
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
033
Cardiovascular risk profile in breast cancer survivors after anthracycline and trastuzumab therapy
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
034
Incidence, clinical profile and outcome of immune checkpoint inhibitor-associated acute interstitial nephritis in patients with solid tumours
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
035
Incidence and timing of thyroiditis and hypophysitis in patients receiving PD-1 or PD-L1 inhibitors
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
036
Clinical, endoscopic and histological spectrum of immune checkpoint inhibitor-induced enterocolitis and response to steroids and infliximab
Immunotherapy & Targeted Therapy
Retrospective record-based study
Descriptive Study
-
037
Homologous recombination deficiency status in high-grade serous ovarian cancer and progression-free survival on PARP inhibitor maintenance
Immunotherapy & Targeted Therapy
Prospective observational study
Prospective Study
-
038
Effect of a supervised home-based exercise programme on cancer-related fatigue during adjuvant chemotherapy for breast cancer
Palliative & Supportive Care
Prospective comparative study
Comparative Study
-
039
Prevalence of cancer cachexia by international consensus criteria and its association with chemotherapy tolerance in advanced gastrointestinal and lung cancer
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
040
Prevalence of sleep disturbance and its association with quality of life in patients receiving chemotherapy
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
041
Netupitant-palonosetron versus aprepitant-based triple antiemetic regimen for highly emetogenic chemotherapy-induced nausea and vomiting
Palliative & Supportive Care
Prospective comparative study
Comparative Study
-
042
Afatinib versus gefitinib or erlotinib as first-line therapy in EGFR exon 19 deletion or L858R non-small cell lung cancer: progression-free survival and toxicity
Immunotherapy & Targeted Therapy
Prospective comparative study
Comparative Study
-
043
Yield of RNA-based fusion testing after negative DNA-based next-generation sequencing in advanced solid tumours
Immunotherapy & Targeted Therapy
Prospective observational study
Diagnostic Study
-
044
Prevalence of psychological distress on the NCCN Distress Thermometer at the first oncology visit and its associated problem domains
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
045
Patient and system delay from symptom onset to start of cancer treatment and the contribution of alternative medicine use
Palliative & Supportive Care
Hospital-based cross-sectional study
Cross-sectional Study
-
046
Incidence and determinants of treatment abandonment and loss to follow-up among patients starting curative-intent chemotherapy
Palliative & Supportive Care
Prospective observational study
Prospective Study
-
047
Tobacco cessation at six months after diagnosis and factors influencing quitting among patients with tobacco-related cancers
Palliative & Supportive Care
Prospective observational study
Prospective Study
-
048
Prevalence of hepatitis B and C infection at cancer diagnosis and adherence to screening and antiviral prophylaxis before chemotherapy
Palliative & Supportive Care
Prospective audit
Audit